Default company panoramic image
B2c99a33 b184 4494 8db7 e120a035343d

Cyteir Therapeutics, Inc

Cyteir is developing a revolutionary, low side effect approach to the treatment of cancer and other diseases of the immune system.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Bar Harbor, ME, US
  • Currency USD
  • Founded June 2012
  • Employees 3
  • Website

Company Summary

Genomic instability is an ‘Achilles heel’ for many cancers and diseases of the immune system – but has not yet been a focus of therapeutic development efforts. Cyteir is a next generation therapeutics enterprise built on a pioneering approach to targeting genomic instability mechanisms with the objective of developing and commercializing new, effective, and low side effect medicines in oncology and immune diseases.


  • Default avatar
    Timothy A Romberger
    CEO and President

    Prior to Cyteir Tim was a Managing Director and Marakon, a small boutique advisory firm that assists multinational companies in the areas of strategy, organizational design and business building. Tim joined Marakon in 1993 and has experience working in North America, Europe and Asia. Tim holds a BS in Economics from the Wharton School at the University of Pennsylvania.

  • Default avatar
    Kevin Mills
    Chief Science Officer

    Kevin Mills is conducts basic and translational studies, as Associate Professor, at the Jackson Laboratory (Bar Harbor). Dr. Mills is Associate Director for Translational Partnerships in the JAX Cancer Center, Joint Faculty at Tufts Medical School, and a member of the UMaine Graduate School. Dr. Mills has published in many high-profile peer reviewed journals. He earned his doctorate in Biology at the Massachusetts Institute of Technology.

  • Default avatar
    David Shaw
    Senior Advisor


  • Default avatar
    Choate-Hall (Bill Asher, Gerald Quirk, Fangli Chen)
    Default avatar
    Sarah Hostetter

Previous Investors

  • Default avatar
    Jackson Laboratory
    Default avatar
    Tim Romberger, Co-Founder